Topamax (topiramate) is now approved to PREVENT migraines

Topamax (topiramate) is now approved to PREVENT migraines.

Nearly half of patients have 50% fewer migraines while on Topamax. This is comparable to current preventive drugs such as tricyclics...divalproex...and beta-blockers.

Patients start on 25 mg/day, then slowly increase up to 50 to 100 mg BID. This is lower than the dose used for seizures.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote